Radiopharm Theranostics

(ASX) RAD

Current Price$0.02

Market Cap$67.34M

Since IPO (2021)-95%

5 YearN/A

1 Year-17%

1 Month-10%

Radiopharm Theranostics Financials at a Glance

Market Cap

$67.34M

Revenue (TTM)

$15.09M

Net Income (TTM)

$86.86M

EPS (TTM)

$-0.02

P/E Ratio

-1.25

Dividend

$0.00

Beta (Volatility)

-0.12 (Low)

Dividend

$0.00

Beta (Volatility)

-0.12 (Low)

Price

$0.02

Volume

833,689

Open

$0.02

Price

$0.02

Volume

833,689

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.04

Dividend

$0.00

Beta (Volatility)

-0.12 (Low)

Price

$0.02

Volume

833,689

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.04

RAD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Radiopharm Theranostics

Industry

Biotechnology

Sector

Health Care

CEO

Riccardo Canevari

Website

radiopharmtheranostics.com

Headquarters

Carlton, VIC 3053, AU

RAD Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-4%

Net Income Margin

-4%

Return on Equity

-86%

Return on Capital

-66%

Return on Assets

-49%

Earnings Yield

-80.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$67.34M

Shares Outstanding

3.54B

Volume

833.69K

Avg. Volume

3.32M

Financials (TTM)

Gross Profit

$9.81M

Operating Income

$38.17M

EBITDA

$31.65M

Operating Cash Flow

$36.65M

Capital Expenditure

$0.00

Free Cash Flow

$36.65M

Cash & ST Invst.

$29.12M

Total Debt

$0.00

Radiopharm Theranostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$1.39M

-65.9%

Gross Profit

$1.25M

+20.3%

Gross Margin

-90.30%

N/A

Market Cap

$67.34M

N/A

Market Cap/Employee

$4.81M

N/A

Employees

N/A

Net Income

$26.97M

-8.9%

EBITDA

$29.75M

-9.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$34.52M

+1722.4%

Accounts Receivable

$11.36M

+157.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-49.29%

N/A

Return on Invested Capital

-65.55%

N/A

Free Cash Flow

$22.67M

-92.6%

Operating Cash Flow

$22.67M

-92.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DOC.AXDoctor Care Anywhere Group PLC

DOC.AXDoctor Care Anywhere Group PLC$0.16+18.52%

CYP.AXCynata Therapeutics Limited

CYP.AXCynata Therapeutics Limited$0.32+0.63%

ATX.AXAmplia Therapeutics Limited

ATX.AXAmplia Therapeutics Limited$0.15+0.00%

PTX.AXPrescient Therapeutics Limited

PTX.AXPrescient Therapeutics Limited$0.05+5.88%

CTE.AXCryosite Limited

CTE.AXCryosite Limited$1.15+0.00%

PIQ.AXProteomics International Laboratories Limited

PIQ.AXProteomics International Laboratories Limited$0.25+6.38%

NSB.AXNeuroScientific Biopharmaceuticals Limited

NSB.AXNeuroScientific Biopharmaceuticals Limited$0.10+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About RAD

What is the current price of Radiopharm Theranostics?

Radiopharm Theranostics is trading at A$0.02 per share.

What is the 52-week range for Radiopharm Theranostics?

Over the past 52 weeks, Radiopharm Theranostics has traded between A$0.02 and A$0.04.

How much debt does Radiopharm Theranostics have?

As of the most recent reporting period, Radiopharm Theranostics reported total debt of N/A.

How much cash does Radiopharm Theranostics have on hand?

Radiopharm Theranostics reported $29.12M in cash and cash equivalents in its most recent financial results.

What is Radiopharm Theranostics’s dividend yield?

Radiopharm Theranostics does not currently have a dividend yield.

Radiopharm Theranostics

Radiopharm Theranostics Financials at a Glance

RAD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Radiopharm Theranostics

RAD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Radiopharm Theranostics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RAD

What is the current price of Radiopharm Theranostics?

What is the 52-week range for Radiopharm Theranostics?

How much debt does Radiopharm Theranostics have?

How much cash does Radiopharm Theranostics have on hand?

What is Radiopharm Theranostics’s dividend yield?

Premium Investing Services